Monday, May 15, 2006

Pain Therapeutics, small cap biopharma pick

Pain Therapeutics(PTIE) engages in the research and development of drugs for use in pain management. The interesting thing about this company is that they have two products in Phase III trials, including Remoxy, which is an anti-abuse version of oxycodone. The stock is also interesting because of inside buying lately, including it's CFO. I'll be adding it to my buy list today.

No comments: